How to buy ResMed stock (RMD)

ResMed is a medical instruments & supplies business based in the US. ResMed shares (RMD) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $231.58 – a decrease of 2.91% over the previous week.

Our top picks for where to buy ResMed stock

Buy ResMed stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

ResMed stock price (NYSE: RMD)

Use our graph to track the performance of RMD stocks over time.

ResMed shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$231.58
52-week range	$162.60 - $259.93
50-day moving average more info button	$242.79
200-day moving average more info button	$219.25
Wall St. target price	$253.11
PE ratio more info button	30.4914
Dividend yield more info button	$1.97 (0.92%)
Earnings per share (TTM) more info button	$7.55

Is it a good time to buy ResMed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ResMed price performance over time

Historical closes compared with the close of $230.21 from 2024-12-18

1 week (2024-12-13)	-3.48%
1 month (2024-11-20)	-4.69%
3 months (2024-09-20)	-6.01%
6 months (2024-06-20)	7.94%

1 year (2023-12-20)	32.33%
2 years (2022-12-20)	12.31%
3 years (2021-12-20)	241.4697
5 years (2019-12-20)	54.02%

Is ResMed stock undervalued or overvalued?

Valuing ResMed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ResMed's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ResMed's P/E ratio

ResMed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, ResMed shares trade at around 30x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

ResMed's PEG ratio

ResMed's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7472. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ResMed's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

ResMed's EBITDA

ResMed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.6 billion.

The EBITDA is a measure of a ResMed's overall financial performance and is widely used to measure a its profitability.

ResMed financials

Revenue TTM	$4.8 billion
Operating margin TTM	31.63%
Gross profit TTM	$2.4 billion
Return on assets TTM	13.27%
Return on equity TTM	23.57%
Profit margin	23.15%
Book value	$35.39
Market Capitalization more info button	$33.8 billion

TTM: trailing 12 months

ResMed share dividends

Dividend payout ratio: 24.37% of net profits

Recently ResMed has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), ResMed shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In ResMed's case, that would currently equate to about $1.97 per share.

While ResMed's payout ratio might seem low, this can signify that ResMed is investing more in its future growth.

ResMed's most recent dividend payout was on 11 December 2024. The latest dividend was paid out to all shareholders who bought their shares by 6 November 2024 (the "ex-dividend date").

Have ResMed's shares ever split?

ResMed's shares were split on a 2:1 basis on 30 August 2010 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your ResMed shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for ResMed shares which in turn could have impacted ResMed's share price.

ResMed share price volatility

Over the last 12 months, ResMed's shares have ranged in value from as little as $162.6047 up to $259.928. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while ResMed's is 0.687. This would suggest that ResMed's shares are less volatile than average (for this exchange).

ResMed overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force.

Frequently asked questions

What percentage of ResMed is owned by insiders or institutions?
Currently 0.773% of ResMed shares are held by insiders and 61.3% by institutions. When does the fiscal year end for ResMed?
ResMed's fiscal year ends in June. Where is ResMed based?
ResMed's address is: 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 What is ResMed's ISIN number?
ResMed's international securities identification number is: US7611521078 What is ResMed's CUSIP number?
ResMed's Committee on Uniform Securities Identification Procedures number is: 761152107